Open AccessEvaluation of the category high-grade squamous intraepithelial lesion in The Bethesda System for reporting cervical cytology
Author(s) -
Sabyasachi Mukhopadhyay,
Sumit Ray,
Supria Dhar,
Ranjana Bandyopadhyay,
Sankar Narayan Sinha
Publication year - 2013
Publication title -
journal of cytology/journal of cytology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.267
H-Index - 19
eISSN - 0974-5165
pISSN - 0970-9371
DOI - 10.4103/0970-9371.107510
Subject(s) - medicine , squamous intraepithelial lesion , bethesda system , dysplasia , carcinoma in situ , cytology , gynecology , predictive value , cervix , pathological , biopsy , positive predicative value , cervical intraepithelial neoplasia , pathology , carcinoma , cervical cancer , cancer
High grade squamous intraepithelial lesion (HSIL) is a category of The Bethesda System (TBS) for reporting cervical cytology that is in vogue since the introduction of the said system in 1988 and it was not modified in 2001 modification of TBS. The term includes moderate dysplasia (CIN II), severe dysplasia (CIN III) and squamous cell carcinoma in situ. Terms like ASC-US used in TBS are being considered to be not very useful in the prediction about the possible behavior of the pathological status of the cervix. After more than 10 years of use the term HSIL also needs fresh evaluation as in this category two entities of potentially different outcome are clubbed.